There were 1,490 press releases posted in the last 24 hours and 399,630 in the last 365 days.
Opinion/decision on a Paediatric investigation plan (PIP): Noxafil, posaconazole, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0200/2023
P/0196/2022 : EMA decision of 9 June 2022 on the acceptance of a modification of an agreed paediatric investigation plan for posaconazole (Noxafil), (EMEA-000468-PIP02-12-M07)
